Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,726
Closed -$220K 602
2023
Q1
$220K Buy
+2,726
New +$219K 0.01% 490
2022
Q3
Sell
-3,833
Closed -$266K 647
2022
Q2
$266K Buy
+3,833
New +$285K 0.01% 461
2020
Q3
Sell
-155
Closed -$9K 469
2020
Q2
$9K Buy
155
+130
+520% +$6.38K ﹤0.01% 579
2020
Q1
$1K Buy
+25
New +$1.19K ﹤0.01% 617
2019
Q4
Sell
-22
Closed -$1K 662
2019
Q3
$1K Buy
+22
New +$1.08K ﹤0.01% 687

Other funds holding HOLX

Balentine LLC's HOLX Position: Q2 2023 in Review

Balentine LLC sold out of Hologic (HOLX) in Q2 2023, closing a stake of 2,726 shares — an estimated $220K sold.

Balentine LLC first reported a position in HOLX in Q3 2019 and held it in 5 quarters. The position peaked at $266K in Q2 2022. 712 funds tracked by Wall St. Rank hold HOLX as of Q2 2023.

  • Balentine LLC reported no remaining Hologic position as of Q2 2023 after selling out during the quarter.
  • Balentine LLC sold 2,726 Hologic shares in Q2 2023, an estimated $220K.
  • Balentine LLC first reported a position in Hologic in Q3 2019 and held it in 5 quarters.
  • Balentine LLC's Hologic position peaked at $266K in Q2 2022.
  • 712 funds tracked by Wall St. Rank held Hologic as of Q2 2023.

Based on Balentine LLC's 13F filing for Q2 2023, filed 14 Aug 2023.